Multicenter, placebo-controlled trial of cabergoline taken once daily in the treatment of Parkinson's disease.
Hutton JT, Koller WC, Ahlskog JE, Pahwa R, Hurtig HI, Stern MB, Hiner BC, Lieberman A, Pfeiffer RF, Rodnitzky RL, Waters CH, Muenter MD, Adler CH, Morris JL.
Hutton JT, et al. Among authors: waters ch.
Neurology. 1996 Apr;46(4):1062-5. doi: 10.1212/wnl.46.4.1062.
Neurology. 1996.
PMID: 8780092
Clinical Trial.